Psoriasis Treatment
That Addresses the Driver —
Not Just the Surface
Plaque psoriasis on the elbows, knees, lower back, and torso is driven by the same IL-23/IL-17 autoimmune loop that causes it everywhere else. Topical corticosteroids suppress the surface. They don't touch the cascade. This 7-component plant-based system does both — simultaneously, without steroids, coal tar, or a prescription.
Get the Home Treatment — $322.91 → Or find a certified Kapyderm Treatment Center near you →Psoriasis affects more than 9 million Americans — and for most of them, the treatment story is the same: a corticosteroid cream that works until you stop using it, coal tar that smells and only does so much, or a biologic that requires a prescription, injections, and a black box warning. The Kapyderm approach is different because it starts with a different question: what does the skin actually need to stop the cycle?
Psoriasis is driven by the IL-23/IL-17 cytokine axis — a self-perpetuating autoimmune loop that continues operating between flares even when skin looks clear. Topical corticosteroids suppress the downstream output of this loop. When you stop, the loop is exactly where it was. That's not a treatment failure — it's a mechanism mismatch. A complete protocol has to address the scalp or skin surface and the systemic inflammatory environment at the same time.
Why Standard Treatments Have a Ceiling
Every conventional psoriasis treatment addresses one part of the problem. Corticosteroids suppress surface inflammation — fast, effective while applied, but the loop continues underneath. Coal tar slows cell turnover at the surface — with documented compliance barriers including strong odor, potential staining, and peer-reviewed notes on potential carcinogenic risk with long-term use. Biologics block the IL-17 or IL-23 pathway directly — genuinely effective for severe disease, but priced at $25,000+ annually with an FDA black box warning. A 7-component botanical system that works on the surface and the internal environment occupies a real clinical gap.
Four Drivers. One Protocol.
The Kapyderm Psoriasis protocol is built around four simultaneous targets — the same architecture used across all Dermotricology treatment systems, adapted for the body psoriasis environment.
Hyperkeratotic Plaque Dissolution
Thick psoriatic plaques physically block any active formula applied on top of them. KS115 dissolves the plaque first — making everything else clinically reachable. This is the step most OTC approaches completely skip.
Skin Microbiome Rebalancing
The skin microbiome in psoriasis patients shows distinct dysbiosis — with pro-inflammatory microbial profiles that sustain inflammation even after visible plaques clear. Fungi-Activ addresses the microbial environment during the recovery and maintenance phases.
Barrier Repair and Hydrolipid Restoration
Psoriatic skin has a structurally compromised barrier — the hydrolipid film is disrupted, allowing irritants to re-enter and perpetuating the inflammatory cycle. K1 Tonic and Special K Cream restore the lipid layer that healthy skin maintains automatically.
Systemic Detox and Nutritional Support
The IL-23/IL-17 cascade operates systemically. No topical product reaches a cytokine loop. dePure (botanical liver support) and Revital (cellular nutritional support) address the internal inflammatory environment that sustains chronic autoimmune skin conditions from within.
The 7-Component System
Two-Phase Protocol
How It Compares to Standard Options
| Treatment | Mechanism | Evidence | Limitations |
|---|---|---|---|
| Coal Tar (T/Gel, MG217) | Slows keratinocyte hyperproliferation | Moderate — mild maintenance only | Strong odor; potential carcinogenic risk; single mechanism; no internal support |
| Topical Corticosteroids (clobetasol, triamcinolone) | Surface anti-inflammatory — fast symptom suppression | Fast clearance — works while applied | Skin thinning; rebound flare on stopping; HPA axis risk with long-term use; no systemic component |
| Roflumilast Cream (Zoryve) — Rx | PDE-4 inhibitor — steroid-free topical anti-inflammatory | Strong steroid-free option; FDA-approved 2022 | Prescription; topical only; no microbiome or internal component |
| Biologics (Skyrizi, Taltz, Cosentyx) | IL-17/IL-23 blockade — targets the systemic driver directly | Excellent for moderate-severe psoriasis | $25,000+/year; injection; black box warning; access barriers |
| Kapyderm Psoriasis Home Treatment | Plaque dissolution + microbiome + barrier repair + internal detox + nutrition | Comprehensive system addressing all 4 drivers simultaneously | No steroids · No coal tar · No prescription · $322.91 |
Who This Treatment Is For
This system is appropriate for people with mild to moderate plaque psoriasis on the body — elbows, knees, lower back, torso, and other non-scalp sites — who want a comprehensive non-pharmaceutical approach, and for people already using pharmaceutical treatments who want to address the internal and microbiome dimensions that prescription topicals don't reach. It is compatible with all skin tones: on darker skin, psoriasis appears as purple, violet, or dark brown patches rather than red — the protocol works regardless of how the condition presents visually.
If your psoriasis is primarily on the scalp, the Scalp Psoriasis protocol uses a different component set (Dandruff Cleanser + Ampoule N instead of Normalizing Base Cleanser) formulated for the scalp's sebum-rich environment and hair-bearing challenges. Both protocols use KS115, K1, Special K Cream, dePure, and Revital — the scalp version adds Ampoule N and a hair-compatible cleanser.
Frequently Asked Questions
7 Components. All Four Drivers.
No Steroids. No Prescription.
Plant-based, EU-regulated, formulated for body psoriasis — elbows, knees, lower back, torso. Addresses the plaque, the microbiome, the barrier, and the internal inflammatory environment simultaneously.